Amicus Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 02:30:00 14/02/2026 am IST			5-day change	1st Jan Change
14.31 ^USD	-0.14%		+0.07%	+0.49%

13/02	BioMarin Pharmaceutical Inc. Announces Closing of Private Offering of Senior Notes	CI
26/01	BioMarin Pharmaceutical Plans $850 Million Notes Offering, Lines Up $2 Billion Syndicated Loan	MT

Published on 12/19/2025 at 09:11 pm IST - Modified on 12/19/2025 at 09:50 pm IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Thank you for standing by. My name is Jayel, and I will be your conference operator today. At this time, I would like to welcome everyone to the

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

13/02	BioMarin Pharmaceutical Inc. Announces Closing of Private Offering of Senior Notes	CI
26/01	BioMarin Pharmaceutical Plans $850 Million Notes Offering, Lines Up $2 Billion Syndicated Loan	MT
30/12	North American Morning Briefing : Stock Futures Muted Ahead of Fed Minutes -2-	DJ
29/12	Leerink Downgrades Amicus Therapeutics to Market Perform From Outperform, Adjusts Price Target to $14.50 From $17	MT
22/12	TD Cowen Downgrades Amicus Therapeutics to Hold From Buy, Adjusts PT to $14.50 From $20	MT
22/12	Dimerix Agrees to Acquire US Licensing Partner for Nearly $5 Billion	MT
20/12	Sector Update: Health Care Stocks Higher Friday Afternoon	MT
19/12	Sector Update: Health Care	MT
19/12	BioMarin Pharmaceutical Inc. submitted a non-binding indication of interest to acquire Amicus Therapeutics, Inc. from The Vanguard Group, Inc., Wellington Management Group LLP, BlackRock, Inc., William Blair Investment Management, LLC, and others for $4.7 billion.	CI
19/12	Amicus Therapeutics, Inc., BioMarin Pharmaceutical Inc. - M&A Call
19/12	BioMarin Pharmaceutical to Acquire Amicus Therapeutics in $4.8 Billion Deal	MT
19/12	BioMarin Pharmaceutical to Acquire Amicus Therapeutics for $4.8 Billion; Shares Jump	MT
19/12	BioMarin to buy Amicus Therapeutics for $4.8 billion in rare disease bet	RE
19/12	BioMarin Pharmaceutical to Acquire Amicus Therapeutics for $4.8 billion	MT
19/12	Biomarin to acquire Amicus Therapeutics for $4.8 billion	RE